Cite
HARVARD Citation
Feagan, B. et al. (n.d.). DOP87 The Anti-TL1A Antibody PRA023 Demonstrated Proof-of-Concept in Crohn's Disease: Phase 2a APOLLO-CD Study Results. Journal of Crohn's and colitis. pp. i162-i164. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Feagan, B. et al. (n.d.). DOP87 The Anti-TL1A Antibody PRA023 Demonstrated Proof-of-Concept in Crohn's Disease: Phase 2a APOLLO-CD Study Results. Journal of Crohn's and colitis. pp. i162-i164. [Online].